Annual ROE
-21.81%
+14.49%+39.92%
31 December 2023
Summary:
Verona Pharma annual return on equity is currently -21.81%, with the most recent change of +14.49% (+39.92%) on 31 December 2023. During the last 3 years, it has risen by +13.43% (+38.11%). VRNA annual ROE is now -923.02% below its all-time high of 2.65%, reached on 31 December 2005.VRNA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-74.15%
-20.96%-39.41%
30 September 2024
Summary:
Verona Pharma quarterly return on equity is currently -74.15%, with the most recent change of -20.96% (-39.41%) on 30 September 2024. Over the past year, it has dropped by -54.37% (-274.87%). VRNA quarterly ROE is now -482.03% below its all-time high of -12.74%, reached on 30 June 2017.VRNA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRNA ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +39.9% | -274.9% |
3 y3 years | +38.1% | -120.6% |
5 y5 years | +30.5% | -46.3% |
VRNA ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +39.9% | -274.9% | at low |
5 y | 5 years | at high | +77.0% | -274.9% | +36.9% |
alltime | all time | -923.0% | +84.2% | -482.0% | +36.9% |
Verona Pharma ROE History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -74.15%(+39.4%) |
June 2024 | - | -53.19%(+116.0%) |
Mar 2024 | - | -24.63%(+17.2%) |
Dec 2023 | -21.81%(-39.9%) | -21.02%(+6.3%) |
Sept 2023 | - | -19.78%(-13.5%) |
June 2023 | - | -22.88%(-25.9%) |
Mar 2023 | - | -30.86%(-23.3%) |
Dec 2022 | -36.30%(+8.7%) | -40.26%(-21.9%) |
Sept 2022 | - | -51.53%(+33.1%) |
June 2022 | - | -38.72%(-2.2%) |
Mar 2022 | - | -39.61%(+14.6%) |
Dec 2021 | -33.39%(-5.2%) | -34.57%(+2.9%) |
Sept 2021 | - | -33.61%(-31.6%) |
June 2021 | - | -49.12%(-4.1%) |
Mar 2021 | - | -51.22%(-13.9%) |
Dec 2020 | -35.24%(-62.9%) | -59.47%(-11.7%) |
Sept 2020 | - | -67.37%(-42.6%) |
June 2020 | - | -117.45%(+20.3%) |
Mar 2020 | - | -97.66%(+39.6%) |
Dec 2019 | -94.90% | -69.97%(+38.1%) |
Sept 2019 | - | -50.67%(+56.5%) |
June 2019 | - | -32.38%(+113.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | -15.18%(-51.1%) |
Dec 2018 | -31.38%(+22.3%) | -31.04%(-10.4%) |
Sept 2018 | - | -34.63%(-16.0%) |
June 2018 | - | -41.23%(-3.2%) |
Mar 2018 | - | -42.58%(+77.9%) |
Dec 2017 | -25.66%(+76.2%) | -23.94%(+14.1%) |
Sept 2017 | - | -20.98%(+64.7%) |
June 2017 | - | -12.74%(-58.4%) |
Mar 2017 | - | -30.60%(+48.0%) |
Dec 2016 | -14.56%(-89.4%) | -20.67%(-67.3%) |
Sept 2016 | - | -63.15%(+293.9%) |
June 2016 | - | -16.03% |
Dec 2015 | -137.93%(+530.1%) | - |
Dec 2014 | -21.89%(-82.1%) | - |
Dec 2013 | -122.09%(+26.3%) | - |
Dec 2012 | -96.68%(+127.7%) | - |
Dec 2011 | -42.46%(-22.6%) | - |
Dec 2010 | -54.85%(+53.7%) | - |
Dec 2009 | -35.68%(+3.9%) | - |
Dec 2008 | -34.33%(-18.5%) | - |
Dec 2007 | -42.14%(+170.1%) | - |
Dec 2006 | -15.60%(-688.7%) | - |
Dec 2005 | 2.65% | - |
FAQ
- What is Verona Pharma annual return on equity?
- What is the all time high annual ROE for Verona Pharma?
- What is Verona Pharma annual ROE year-on-year change?
- What is Verona Pharma quarterly return on equity?
- What is the all time high quarterly ROE for Verona Pharma?
- What is Verona Pharma quarterly ROE year-on-year change?
What is Verona Pharma annual return on equity?
The current annual ROE of VRNA is -21.81%
What is the all time high annual ROE for Verona Pharma?
Verona Pharma all-time high annual return on equity is 2.65%
What is Verona Pharma annual ROE year-on-year change?
Over the past year, VRNA annual return on equity has changed by +14.49% (+39.92%)
What is Verona Pharma quarterly return on equity?
The current quarterly ROE of VRNA is -74.15%
What is the all time high quarterly ROE for Verona Pharma?
Verona Pharma all-time high quarterly return on equity is -12.74%
What is Verona Pharma quarterly ROE year-on-year change?
Over the past year, VRNA quarterly return on equity has changed by -54.37% (-274.87%)